54383 - ESG in Life Sciences Summit Europe

Redefine Tomorrow's ESG Standards Today to Drive Industry-Wide Progression

Unprecedented, pivotal changes in the global ESG and sustainability regulatory landscape in Europe have landed business leaders under immense pressure to make their life sciences organisation a more environment-friendly and socially conscious business at its core. Therefore, now is the time to join us at the world's first and only forum dedicated to tackling the strategic ESG and sustainability challenges encountered by life sciences organisations of all stages and sizes in Europe.

The ESG in Life Sciences Summit Europe 2024 will unite 60+ life sciences ESG, sustainability, CSR, EHS, legal, and finance leaders in Europe, as well as other key stakeholders (such as governing bodies, regulators, investors, and healthcare systems) to provide a much-needed platform for industry-wide discussions on how life sciences can lead the forefront of global ESG advancement.

Prices:
Conference Only - Drug Developer Pricing: EUR 2799.00,
Conference + 1 Workshop - Drug Developer Pricing: EUR 3298.00,
Conference + 2 Workshops - Drug Developer Pricing: EUR 3797.00,
Conference Only - Academic Pricing: EUR 2399.00,
Conference + 1 Workshop - Academic Pricing: EUR 2798.00,
Conference + 2 Workshops - Academic Pricing: EUR 3197.00,
Conference Only - Vendor Pricing: EUR 3399.00,
Conference + 1 Workshop - Vendor Pricing: EUR 4198.00,
Conference + 2 Workshops - Vendor Pricing: EUR 4597.00

Speakers: Adam Liddle, Head of Sustainability, Roslin Cell Therapies Ltd. (Roslin CT), Andrea Cirlicova, Global Scope 3 and Supplier Engagement Lead, Environmental Sustainability, Novartis AG, Anne Frost, ESG and Reporting Director, Kyowa Kirin Pharma, Anne-Laure Demarcy, Global Head of Environmental Sustainability, UCB S.A., Arun Skaria, Senior Director Corporate Responsibility and ESG, Alnylam Pharmaceuticals, Barbara Giorgio, Supply Chain, Procurement and Maintenance Director, ExcellGene SA, Byron Austin, Global Head of ESG, Sustainability, and Corporate Responsibility, Organon Pharmaceuticals, Chris Low, Director Sustainability Procurement and Packaging, Haleon, Christoffer Falkman, Director - Environmental, Social and Governance, Bavarian Nordic, Ester Lovsin Barle, Global Head Product Sustainability and Stewardship, Takeda Pharmaceutical Co. Ltd., Gareth Collins, Vice President, Head of Sustainability, Ipsen Pharma, Guillermo Angeleri, Senior Manager - Environmental, Social and Governance, Centrient Pharmaceuticals, Matteo Alaria, Head of Sustainability BPS, Sartorius, Sandrine Bouttier Stref, Group Head of Corporate Social Responsibility, Sanofi, Veronique Toully, Global Head Sustainability, Corporate Affairs and Risk, UCB S.A.

Others Details

Brochure: https://go.evvnt.com/2297589-3?pid=6581